75 related articles for article (PubMed ID: 7574735)
1. [Pharmacokinetic study of intraperitoneally administered plachitin for non-curative gastrointestinal cancer].
Tabara H; Kinugasa S; Tachibana M; Abe S; Yoshimura H; Suzuki K; Monden N; Nakamura T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1473-6. PubMed ID: 7574735
[TBL] [Abstract][Full Text] [Related]
2. [A new trial of plachitin particles for intraarterial chemoembolization therapy in rabbit].
Tabara H; Matsuura H; Tachibana M; Yoshimura H; Kotoh T; Dhar DK; Nagasue N; Nakamura T; Kifune K; Tsurutani R
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1582-5. PubMed ID: 8373224
[TBL] [Abstract][Full Text] [Related]
3. [Intraarterial chemoembolization therapy for unresectable liver cancer using plachitin particles].
Tabara H; Matsuura H; Kohno H; Hayashi T; Nagasue N; Nakamura T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2225-8. PubMed ID: 7944446
[TBL] [Abstract][Full Text] [Related]
4. [Slow releasing anticancer drug containing CDDP for intraoperative use in residual cancer cells].
Suzuki K; Matsuura H; Yoshimura H; Koto T; Tabara H; Nakamura T; Kifune K; Tsurutani R; Yoshimura M; Nakamura Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1728-30. PubMed ID: 1530342
[TBL] [Abstract][Full Text] [Related]
5. [Development of slow releasing anticancer drug based with absorbable biomaterial chitin].
Suzuki K; Nakamura T; Tachibana M; Koto T; Yoshimura H; Abe S; Kifune K; Tsurutani R; Yoshimura M; Nakamura Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1833-6. PubMed ID: 1877826
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
Koda K; Nakazawa O; Terada S; Kure T; Morita K; Hirayama M; Fukushi A; Terui T; Yoshizaki N; Takahashi H
Gan No Rinsho; 1988 Feb; 34(2):191-5. PubMed ID: 3126333
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer].
Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
[TBL] [Abstract][Full Text] [Related]
9. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
10. A new drug delivery system for local cancer chemotherapy using cisplatin and chitin.
Suzuki K; Nakamura T; Matsuura H; Kifune K; Tsurutani R
Anticancer Res; 1995; 15(2):423-6. PubMed ID: 7763016
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
Deng C; Huang R; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
[TBL] [Abstract][Full Text] [Related]
12. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
13. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
14. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
[TBL] [Abstract][Full Text] [Related]
15. [Study of serum CDDP concentrations in patients with advanced or recurrent adeno-or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)].
Yagihashi A; Sasaki K; Hirata K; Yamamitsu S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):63-7. PubMed ID: 8546471
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic study of intraperitoneal cisplatin chemotherapy for gastric cancer as an adjuvant setting].
Kochi M; Fujii M; Takano S; Kato Y; Kawakami T; Kanamori N; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1535-7. PubMed ID: 7574752
[TBL] [Abstract][Full Text] [Related]
17. [Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinum microcapsule in rabbits].
Wang Y
Zhonghua Wai Ke Za Zhi; 1990 Nov; 28(11):686-8, 704. PubMed ID: 2086077
[TBL] [Abstract][Full Text] [Related]
18. [The comparison of absorptive routes of intraperitoneal infusion with cisplatin in dogs].
Namatame K; Kou Y; Sasaki E; Nakayoshi A
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1716-9. PubMed ID: 1530339
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
